Introduction
In their experimental study of subjects who experienced hyperbaric exposure, Risberg, Englund, Aaanderud and Eftedal (2004) suggested need for further investigations to explore the relationship of individual characteristics with effects of hyperbaric exposure. Drawing on articles in the literature, I present here a discursive kind discussion of three topics: 1) the basic physiology of hyperbaric exposure, 2) two major environments of hyperbaric exposure, and 3) certain risks in hyperbaric exposure and some of the population groups implicated.
Hyperbaric Exposure: Physiology Put simply, hyperbaric exposure refers to the experience of the pressure of gas at levels above the normal pressure for an atmosphere. The key to understanding the significance of hyperbaric exposure for human beings lies in understanding the physiological implications of this phenomenon as outlined in the literature of Adams (1964) , which is the reference point for the next two paragraphs. The key to the significance of hyperbaric exposure is the impact of the partial pressure of a gas on the human body. Partial pressure is produced when ambient pressure is increased by any percent concentration of a gas. The impact of a gas on the human body is proportional to its partial pressure on the body. When humans breathe 100% oxygen at sea level/earth's surface, the partial pressure of oxygen is one atmosphere times 20%; this equals 0.2 atmospheres of oxygen. If humans breathe 100% oxygen at sea level/earth's surface, the partial pressure of oxygen is one atmosphere times 100%; this equals one atmosphere of oxygen. When humans breathe oxygen at four times the pressure that the body experiences at sea level/earth's surface, the partial pressure is 4 atmospheres times 100; this equals 4 atmospheres of oxygen. Inspired oxygen is carried in the blood as oxyhemoglobin and as dissolved oxygen. Hemoglobin, though important in normal conditions, has limited capacity to transport oxygen. Dissolved oxygen is present in blood plasma, liquid blood, and its volume is limited by the partial pressure of oxygen to which a person is exposed. The more intense the partial pressure of oxygen, the larger the volume of dissolved oxygen. This is the amount of oxygen that the blood releases as it passes through the tissues and returns to the heart. Breathing air at sea level/earth's surface, 0.3cc of oxygen is dissolved in every 100cc of blood. As pressure rises, the amount of oxygen dissolved increases exponentially. In a hyperbaric exposure www.jmscr.igmpublication. Air supply is crucial to function and survival in a diving environment. Naturally, in the logic of the physiology of hyperbaric exposure, divers have to breathe air at pressures which increase exponentially with depth: typically, divers breathe at a pressure of 4 atmospheres absolute. A corresponding effect is the occurrence of an equalisation of pressure in the middle ear spaces, sinuses, and lungs. All divers are at risk for negative effects of hyperbaric exposure. Their prime hyperbaric exposure risk is twofold: 1) air embolism, particularly venous gas embolism (VGE), a subset of arterial gas embolism, in which gas bubbles form in the systemic venous system; 2) decompression sickness (DCS), which many observers hold as a concomitant condition of VGE. Strauss and Borer (2001) depict air embolism and DCS as characteristic problems of diving activity. According to the literature of Stoloff, Isenberg and Brill (2001) the pathophysiology of DCS is the development of gas bubbles in the central venous circulation along a pressure gradient. Retention of gas bubbles in the body during diving activity can cause decompression sickness, notably during rapid continuous ascent in the concluding phase of diving. The lethality of these gas bubbles depends to a large degree on their absolute size. Diagnosis of VGE and DCS, discretely, or combined as cause and effect can be elusive and controversial. Speaking to VGE, Stoloff, Isenberg and Brill (2001, p. 185) observe: The clinical diagnosis of venous gas embolism may be difficult because of the wide range of symptoms that are similar to those of other acute cardiopulmonary and cerebro-vascular conditions. If small volumes of gas are entrained and symptoms are few, the condition may be unrecognizable. If symptoms are present, they may be ascribed to another etiology. On DCS, Petri and Andric (2003, pp.26, 27) opine that determination of DCS remains under developed: "we do not have sufficient knowledge to date concerning DCS pathophysiology, onset, and treatment" and "DCS symptoms vary to such a degree from case to case that it has been said that there is no DCS, but merely people who contract it." And Strauss and Borer (2001, p.234) "The correlation of VGE with the symptoms of DCS are [sic] relatively poor.
[And] the clearing of Doppler detectable bubbles from the blood stream is not associated with recovery from DCS." These observations imply that divers who succumb to acute VGE are at risk for inaccurate diagnosis, and, in turn, inappropriate treatments.
Medical environment
In the medical services environment, hyperbaric exposure occurs therapeutically, in hyperbaric medicine, that is hyperbaric oxygen therapy (HBOT), which The Undersea and Hyperbaric Medical Society defines as: ...a treatment, in which a patient breathes 100% oxygen intermittently while inside a treatment chamber at a pressure higher than sea level pressure (i.e.>1 atmosphere absolute, atm.abs). It can be viewed as the new application of an old, established technology to help resolve certain, recalcitrant, expensive, or otherwise hopeless medical problems. In certain circumstances, it represents the primary treatment modality while in others it is an adjunct to surgical or pharmacologic interventions In an historical note, Leifer (2001) traces a close association between the development of hyperbaric medicine and improvements in diving equipment from the age of Alexander the Great to the current era. Leifer (2001) cites the list of conditions, for which HBOT is approved by the Undersea and Hyperbaric Medical Society:
 Air embolism  Thermal burns  Carbon monoxide and cyanide poisoning  Traumatic ischemias such as compartment syndrome or crush injuries  Anemia resulting from exceptional blood loss  Non healing wounds  Anaerobic cellulitis or gas gangrene  Decompression illness ('the bends')  Acute peripheral arterial insufficiency  Osteomyelitis  Radiation tissue damage including osteoradionecrosis  Actinomycosis  Intra cranial abscesses  Compromised skin grafts or flaps HBOT treatment is administered in specially constructed, pressure controlled chambers, of which there are two types: the mono-place chamber, which holds only one patient and does not allow hands-on treatment measures; the multi-place chamber, which can hold up to 12 to 18 patients and equipment for treatments. Both chambers are pressurised with 100% oxygen. In the multi-place chamber, the patient breathes 100% oxygen through a hood or mask. However, HBOT is a controversial field. Chen The background to these cautionary counsels is the breathing process in hyperbaric oxygenation circumstances.
Hyperbaric oxygenation and breathing
In the normal breathing environment of room air, an individual breathes air with a gas composition of 21% oxygen and 79% nitrogen. In the breathing process, the following phenomena ensue: the oxygen exchanges for carbon monoxide at the alveolar-capillary membrane, the tissue barrier through which gases are exchanged between the alveolar air and the pulmonary capillaries; the nitrogen content in the residual alveolar air remains relatively stable and is partially responsible for the resiliency of the alveolus. When a person breathes pure oxygen in a hyperbaric exposure environment such as HBOT, the residual nitrogen quickly moves out of the alveolus and is replaced with pure oxygen. Subsequent hyperventilation or obstruction to alveolar ventilation would then favor absorption of that residual oxygen, leading, potentially, to the collapse of the alveolus. Leifer (2001, p. 29) acknowledges the pulmonary risk of hyperbaric oxygenation but, at the same time, notes that duration is a key mediating factor: "Oxygen can be toxic to the lungs. 1003) also note that "much more needs to be learned" about the "high co-occurrence" of ASD and seizures, and they recommend that clinicians should be mindful of this phenomenon during assessment. This advice is very pertinent to assessment for prospective HBOT.
Conclusion
The studies that have been outlined in this article underscore that there is room for improvement in knowledge about the role of hyperbaric exposure in some conditions of patients who are under consideration for HBOT. The development of this knowledge would enhance decision making on HBOT application.
